These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 6332172)

  • 1. Clinical significance of antibodies to Sm (Smith) and RNP (ribonucleoprotein) in patients with rheumatic diseases.
    Tsay GJ; Su CB; Chen TY; Lin CS
    Taiwan Yi Xue Hui Za Zhi; 1984 May; 83(5):436-43. PubMed ID: 6332172
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of antibodies to ribonucleoprotein and Sm antigens with mixed connective-tissue disease, systematic lupus erythematosus and other rheumatic diseases.
    Sharp GC; Irvin WS; May CM; Holman HR; McDuffie FC; Hess EV; Schmid FR
    N Engl J Med; 1976 Nov; 295(21):1149-54. PubMed ID: 1086429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies to Sm and RNP. Prognosticators of disease involvement.
    Munves EF; Schur PH
    Arthritis Rheum; 1983 Jul; 26(7):848-53. PubMed ID: 6603221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of IgG anti-Sm antibodies in patients with systemic lupus erythematosus.
    Yasuma M; Takasaki Y; Matsumoto K; Kodama A; Hashimoto H; Hirose S
    J Rheumatol; 1990 Apr; 17(4):469-75. PubMed ID: 2348425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of anti-ENA, Sm and RNP antibodies in patients with antinuclear antibodies.
    Levo Y; Lotan C
    Isr J Med Sci; 1982 Feb; 18(2):287-9. PubMed ID: 6978327
    [No Abstract]   [Full Text] [Related]  

  • 6. Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm.
    Eisenberg RA; Dyer K; Craven SY; Fuller CR; Yount WJ
    J Clin Invest; 1985 Apr; 75(4):1270-7. PubMed ID: 3872886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Idiotypic independency of anti-dsDNA and anti-Sm antibodies in SLE sera.
    Kubota T; Dang H; Takei M; Miyasaka N; Kanai Y; Talal N
    Clin Exp Rheumatol; 1989; 7(5):572-3. PubMed ID: 2591135
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibodies to Sm in patients with systemic lupus erythematosus. Correlation of Sm antibody titers with disease activity and other laboratory parameters.
    Barada FA; Andrews BS; Davis JS; Taylor RP
    Arthritis Rheum; 1981 Oct; 24(10):1236-44. PubMed ID: 6975630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
    Molden DP; Suzuki H; Nakamura RM
    Diagn Immunol; 1985; 3(1):24-8. PubMed ID: 3922661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC; Barcellos KS; Andrade LE
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Special antibodies for the study of systemic lupus erythematosus: an analysis.
    Tan EM
    Arthritis Rheum; 1982 Jul; 25(7):753-6. PubMed ID: 6980650
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibodies to antinuclear subsets in systemic lupus erythematosus and rheumatoid arthritis.
    Smolen JS; Hassfeld W; Graninger W; Steiner G
    Clin Exp Rheumatol; 1990; 8 Suppl 5():41-4. PubMed ID: 2245525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New directions in antinuclear antibody research: the Sm, RNP, Ro, and La antigens are found on small-RNA protein particles.
    Hardin JA; Lerner MR; Lerner EA; Steitz JA
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):98-100. PubMed ID: 6179414
    [No Abstract]   [Full Text] [Related]  

  • 14. Anti-Sm: its predictive value in systemic lupus erythematosus.
    Janwityanuchit S; Verasertniyom O; Vanichapuntu M; Vatanasuk M
    Clin Rheumatol; 1993 Sep; 12(3):350-3. PubMed ID: 8258234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antinuclear autoantibodies on RNA polymerase.
    Hough DW; Miller NI; Maddison PJ
    Immunol Lett; 1983 Mar; 6(3):123-7. PubMed ID: 6602760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antinuclear antibodies in systemic lupus erythematosus.
    Fong KY; Boey ML; Howe HS; Feng PH
    Med J Malaysia; 1989 Jun; 44(2):151-5. PubMed ID: 2626124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic value of anti-RNP/Sm and anti-Ro/La antibodies in lupus nephropathy].
    López-Longo FJ; López-Gómez JM; Jofre Ibáñez R; Escalona M; Rodríguez-Mahou M
    Rev Clin Esp; 1992 Nov; 191(7):354-9. PubMed ID: 1475460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of anti-RNP and anti-Sm antibodies in MCTD and SLE patients by immunoblotting.
    Habets WJ; de Rooij DJ; Hoet MH; van de Putte LB; van Venrooij WJ
    Clin Exp Immunol; 1985 Feb; 59(2):457-66. PubMed ID: 3884199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical significance of the anti-Sm antibody].
    Chen DL
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):13-5. PubMed ID: 3109698
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoblotting profiles in 55 systemic lupus erythematosus sera lacking precipitating antibodies to extractable nuclear antigens.
    Meyer O; Bourgeois P; Aeschlimann A; Haim T; Mery JP; Kahn MF
    Ann Rheum Dis; 1989 Jul; 48(7):594-9. PubMed ID: 2789021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.